Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

Rigetti Computing, Inc. is a speculative, high-beta play on the commercialization of superconducting quantum computing. While the company has demonstrated strong technical execution—notably launching its 108-qubit Cepheus-1-108Q system and achieving up to 99.8% median two-qubit gate fidelity—its commercial revenues remain small and lumpy. A strong balance sheet with $569 million in cash and no debt, bolstered by a non-binding letter of intent for up to $100 million in CHIPS Act funding, provides a multi-year runway. However, extreme valuation multiples and intense competition from tech giants warrant a cautious Hold stance until consistent commercial traction is established.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets12 analysts · as of 18 Aug 2026
Low · most bearish analyst$18.00
Mean target$28.81
High · most bullish analyst$40.00
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario

Technical hurdles delay the 1,000+ qubit roadmap, and the CHIPS Act funding fails to materialize or comes with highly restrictive covenants. Commercial demand for on-premises QPUs stalls, leading to accelerated cash burn and dilutive capital raises before 2030.

Base CaseCentral scenario

Rigetti successfully executes its technical roadmap, scaling to a 150+ qubit system in 2026 and progressing toward 1,000+ qubits by 2027. The non-binding CHIPS Act letter of intent is finalized into a definitive $100 million agreement, securing its long-term R&D runway. Revenue scales gradually through Novera QPU deliveries and government contracts, but profitability remains several years away.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • Strong balance sheet with $569 million in cash, cash equivalents, and available-for-sale investments as of Q1 2026, and zero debt.
  • Validation from the U.S. government via a non-binding letter of intent for up to $100 million in CHIPS Act funding.
  • Successful launch and general availability of the 108-qubit Cepheus-1-108Q modular quantum processor.
  • Superconducting qubit architecture offers fast gate speeds (50-70ns), significantly faster than trapped-ion or neutral-atom modalities.
Sign in / Sign up to read more
Key Investment Risks
  • Extremely high valuation multiples relative to current trailing revenues ($10.02 million TTM revenue).
  • Lumpy and unpredictable revenue patterns due to early-stage commercialization and high customer concentration.
  • Intense competition from well-capitalized tech giants (IBM, Google) and pure-play peers (IonQ, D-Wave).
  • Long development cycles and high execution risk associated with achieving fault-tolerant quantum computing.
Sign in / Sign up to read more
Thesis Invalidation Triggers
  1. Failure to finalize the $100 million CHIPS Act funding agreement.
  2. Significant delays in the deployment of the 150+ qubit or 1,000+ qubit systems.
  3. Quarterly cash burn accelerating beyond $25 million without a corresponding increase in revenue.
  4. A breakdown in key cloud distribution partnerships with Amazon Braket or Microsoft Azure Quantum.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.